An explanation for the low quality antibodies produced during serious SARS-CoV-2 infection
…recently identified as a biomarker that may predict serious disease. Monoclonal antibodies to TNF-alpha are licensed for the treatment of other diseases such as rheumatoid arthritis, and could be assessed…
